home / stock / xlo / xlo articles


XLO Articles, Xilio Therapeutics Inc. - From 01/31/24

Stock Information

Company Name: Xilio Therapeutics Inc.
Stock Symbol: XLO
Market: NASDAQ

Menu

XLO XLO Quote XLO Short XLO News XLO Articles XLO Message Board
Get XLO Alerts

News, Short Squeeze, Breakout and More Instantly...

Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference | Benzinga

WALTHAM, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and ...

Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR...

Xilio to Host Virtual Investor Conference Call and Webcast on Monday, November 6, 2023 to Review Progress Across Pipeline, Including Phase 1/2 Clinical Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, Presented at the SITC Annual Meeting |

WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and ...

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting | Benzinga

WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and...

Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer | Benzinga

WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and...

Xilio Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference | Benzinga

WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and...

Previous 10 Next 10